| In millions, except per share items | Feb-28-23 | Feb-28-22 | Feb-28-21 | Feb-29-20 | Feb-28-19 | Feb-28-18 | Feb-28-17 | Feb-29-16 |
| | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| United States | | 506.2 | 477.6 | 322.6 | 393.8 | 446.3 | 449.9 | 461.6 |
| Other | | 129.7 | 86.0 | 72.3 | 53.0 | 60.8 | 64.7 | 68.6 |
| Total revenues | 534.0 | 635.9 | 563.6 | 394.9 | 446.8 | 507.1 | 514.5 | 530.2 |
| Revenue growth [+] | -16.0% | 12.8% | 42.7% | -11.6% | -11.9% | -1.4% | -3.0% | -30.0% |
| United States | | 6.0% | 48.0% | -18.1% | -11.7% | -0.8% | -2.5% | |
| Cost of goods sold | 399.7 | 466.4 | 405.1 | 285.1 | 325.4 | 374.8 | 370.5 | 386.7 |
| Gross profit | 134.3 | 169.5 | 158.5 | 109.8 | 121.4 | 132.3 | 144.0 | 143.5 |
| Gross margin | 25.1% | 26.7% | 28.1% | 27.8% | 27.2% | 26.1% | 28.0% | 27.1% |
| Selling, general and administrative [+] | 121.5 | 126.5 | 113.6 | 108.2 | 107.9 | 125.0 | 122.7 | 127.8 |
| Sales and marketing | 47.0 | 50.5 | 43.8 | 39.3 | 40.9 | 46.0 | 43.1 | 43.6 |
| General and administrative | 74.5 | 76.0 | 69.8 | 68.9 | 66.9 | 79.0 | 79.6 | 84.2 |
| Research and development | | | | | | | | |
| Equity in earnings | | 7.9 | 7.4 | 5.2 | 6.6 | 7.2 | 6.8 | 6.5 |
| Other operating expenses | 31.5 | 35.1 | 21.2 | 21.7 | 27.9 | 26.4 | 29.5 | 32.0 |
| EBITDA [+] | | 28.2 | 42.2 | -2.5 | 4.7 | 3.2 | 11.0 | -0.1 |
| EBITDA growth | -166.1% | -33.1% | -1785.8% | -153.6% | 46.3% | -71.0% | -14985.1% | -100.2% |
| EBITDA margin | -3.5% | 4.4% | 7.5% | -0.6% | 1.0% | 0.6% | 2.1% | 0.0% |
| Depreciation | | 5.9 | 5.6 | 5.4 | 5.4 | 8.6 | 5.9 | 4.7 |
| EBITA | -18.6 | 22.3 | 36.6 | -7.9 | -0.7 | -5.4 | 5.1 | -4.8 |
| EBITA margin | -3.5% | 3.5% | 6.5% | -2.0% | -0.2% | -1.1% | 1.0% | -0.9% |
| Amortization of intangibles | | 6.5 | 5.4 | 7.0 | 7.0 | 6.5 | 6.5 | 5.0 |
| EBIT [+] | -18.6 | 15.8 | 31.1 | -14.9 | -7.7 | -11.9 | -1.4 | -9.7 |
| EBIT growth | -217.9% | -49.2% | -308.9% | 94.1% | -35.6% | 769.5% | -85.9% | -168.1% |
| EBIT margin | -3.5% | 2.5% | 5.5% | -3.8% | -1.7% | -2.4% | -0.3% | -1.8% |
| Non-recurring items [+] | 8.6 | | 1.3 | 30.2 | 26.9 | | | 0.8 |
| Asset impairment | 8.7 | | 1.3 | 30.2 | 22.3 | | | |
| Interest expense | | 2.5 | 3.0 | 3.0 | 4.4 | 6.0 | 7.1 | 7.9 |
| Interest expense | | 2.5 | 3.0 | 3.0 | 4.4 | 6.0 | 7.1 | 7.9 |
| Other income (expense), net [+] | -3.7 | -39.1 | 0.8 | 7.2 | -19.9 | -6.2 | -0.5 | 5.3 |
| Acquisition-related costs | | 3.6 | 0.3 | 0.1 | | | | |
| Realized gain (loss) on investments | | | | | -0.5 | 1.4 | | |
| Gain (loss) on foreign currency transactions | | | | | | | -0.5 | 0.1 |
| Other | -2.1 | 0.3 | 1.5 | 2.3 | -1.1 | -7.6 | -1.2 | -0.2 |
| Pre-tax income | -31.0 | -25.8 | 27.6 | -40.9 | -59.0 | -24.1 | -8.9 | -13.2 |
| Income taxes | 0.0 | 1.6 | 4.3 | 0.9 | -6.1 | -17.4 | 0.3 | -2.4 |
| Tax rate | 0.1% | | 15.5% | | 10.4% | 72.4% | | 17.8% |
| Minority interest | -2.3 | -5.1 | -3.4 | -15.4 | -6.7 | -7.3 | -7.6 | -3.4 |
| Net income | -30.9 | -22.3 | 26.8 | -26.4 | -46.1 | 35.3 | -4.8 | -13.5 |
| Net margin | -5.8% | -3.5% | 4.7% | -6.7% | -10.3% | 7.0% | -0.9% | -2.5% |
| |
| Basic EPS [+] | ($1.27) | ($0.92) | $1.11 | ($1.08) | ($1.89) | $1.45 | ($0.20) | ($0.56) |
| Growth | 38.2% | -183.1% | -202.0% | -42.7% | -230.2% | -824.6% | -64.1% | 1342.8% |
| Diluted EPS [+] | ($1.27) | ($0.92) | $1.09 | ($1.08) | ($1.89) | $1.44 | ($0.20) | ($0.56) |
| Growth | 38.2% | -184.7% | -200.2% | -42.7% | -231.6% | -817.0% | -64.1% | 1342.8% |
| |
| Shares outstanding (basic) [+] | 24.3 | 24.3 | 24.2 | 24.4 | 24.4 | 24.3 | 24.2 | 24.2 |
| Growth | 0.2% | 0.4% | -0.8% | 0.2% | 0.3% | 0.5% | -0.1% | -0.6% |
| Shares outstanding (diluted) [+] | 24.3 | 24.3 | 24.7 | 24.4 | 24.4 | 24.5 | 24.2 | 24.2 |
| Growth | 0.2% | -1.5% | 1.0% | 0.2% | -0.8% | 1.6% | -0.1% | -0.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |